WSJ
11 Jun 2026, 15:42 UTC · 2h ago
Novo Nordisk's Wegovy Weight Loss Pill Approved in the U.K.
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Top 1 mover · tap to explore
WSJ
11 Jun 2026, 15:42 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Top 1 mover · tap to explore
What the story claims
1 claim · each scored for market impact
The U.K. regulator has licensed a new obesity medicine from a Danish drugmaker. — Regulatory approval opens a new revenue stream and expands market access for a high-growth therapeutic area.
+0.60Go deeper
You just saw which tickers this one story hits. A free account turns that into a standing screen: the movers delivered on schedule, before the chart catches up.
On this page · free
In the platform
Free account, 30 seconds. No credit card. Covers all 10 tickers this story moves.
How the impact breaks down
Where the story's weight lands
Continue reading
6 related stories
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Screener bridge
Catch the names this kind of story moves — before the chart does.
Get the full NIS Momentum results every Friday at 4PM ET — free via email or Telegram.
Zacks Investment Research
2h ago
